Synthetic Biology Patent Application Trends 2025

Synthetic Biology patent applications in 2025

Top Technology Areas in Synthetic Biology

Top CPC Codes

• C12N9/22 (No explanation available)
  • Count: 18 patents
  • Example: 20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)
• C12N2310/20 (No explanation available)
  • Count: 16 patents
  • Example: 20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)
• C12N15/11 (No explanation available)
  • Count: 9 patents
  • Example: 20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC)
• C12N15/907 (No explanation available)
  • Count: 9 patents
  • Example: 20250064980. Materials and Methods for Treatment of Duchenne Muscular Dystrophy (Vertex Pharmaceuticals Incorporated)
• C12N15/111 (No explanation available)
  • Count: 7 patents
  • Example: 20250066798. COMPOSITIONS FOR INDUCING MODIFICATIONS OF TARGET ENDOGENOUS NUCLEIC ACID SEQUENCES IN NUCLEUSES OF EUKARYOTIC CELLS (ToolGen Incorporated)
• A61P35/00 (No explanation available)
  • Count: 5 patents
  • Example: 20250032547. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.)
• A61K39/4611 (No explanation available)
  • Count: 4 patents
  • Example: 20250032547. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.)
• A61K39/4631 (No explanation available)
  • Count: 4 patents
  • Example: 20250032547. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.)
• C12N15/113 (No explanation available)
  • Count: 4 patents
  • Example: 20250064980. Materials and Methods for Treatment of Duchenne Muscular Dystrophy (Vertex Pharmaceuticals Incorporated)
• A61K39/4613 (No explanation available)
  • Count: 3 patents
  • Example: 20250032547. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.)

Top Companies in Synthetic Biology 2025

FATE THERAPEUTICS, INC.

• Number of Synthetic Biology patents: 3
• Top CPC codes:
  • A61K39/4611 (No explanation available): 3 patents
  • A61K39/4613 (No explanation available): 3 patents
  • A61K39/4631 (No explanation available): 3 patents
• Recent patents:
  • 20250032547. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250130)
  • 20250000904. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250102)
  • 20250018034. ENGINEERED EFFECTOR CELLS AND METHODS OF ENHANCING UBIQUITOUS TARGETING OF SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250116)

PIONEER HI-BRED INTERNATIONAL, INC.

• Number of Synthetic Biology patents: 2
• Top CPC codes:
  • A01H1/1255 (No explanation available): 1 patents
  • A01H1/04 (No explanation available): 1 patents
  • C12Q1/6895 (No explanation available): 1 patents
• Recent patents:
  • 20250000042. COMPOSITIONS AND METHODS FOR GRAY LEAF SPOT RESISTANCE (PIONEER HI-BRED INTERNATIONAL, INC.) (20250102)
  • 20250002930. METHODS OF IDENTIFYING, SELECTING, AND PRODUCING SOUTHERN CORN RUST RESISTANT CROPS (PIONEER HI-BRED INTERNATIONAL, INC.) (20250102)

OMNI MEDSCI, INC.

• Number of Synthetic Biology patents: 2
• Top CPC codes:
  • A61B5/0088 (No explanation available): 2 patents
  • A61B5/0013 (No explanation available): 2 patents
  • A61B5/0022 (No explanation available): 2 patents
• Recent patents:
  • 20250017473. WEARABLE DEVICE FOR DIFFERENTIAL MEASUREMENT ON PULSE RATE AND BLOOD FLOW (OMNI MEDSCI, INC.) (20250116)
  • 20250049326. WEARABLE DEVICE FOR DIFFERENTIAL MEASUREMENT ON PULSE RATE AND BLOOD FLOW (OMNI MEDSCI, INC.) (20250213)

Prime Medicine, Inc.

• Number of Synthetic Biology patents: 2
• Top CPC codes:
  • C12N9/1276 (No explanation available): 2 patents
  • C12N9/22 (No explanation available): 2 patents
  • C12N2310/20 (No explanation available): 2 patents
• Recent patents:
  • 20250073352. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF FRAGILE X SYNDROME (Prime Medicine, Inc.) (20250306)
  • 20250011766. Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis (Prime Medicine, Inc.) (20250109)

BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM

• Number of Synthetic Biology patents: 2
• Top CPC codes:
  • C12N15/1037 (No explanation available): 1 patents
  • C07K14/705 (No explanation available): 1 patents
  • C12N9/22 (No explanation available): 1 patents
• Recent patents:
  • 20250027072. METHODS AND COMPOSITIONS RELATED TO ENGINEERED CANNABINOID RECEPTORS (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM) (20250123)
  • 20250051862. METHODS AND COMPOSITIONS RELATED TO ENGINEERED BIOSENSORS (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM) (20250213)

The Regents of the University of California

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12N5/06 (No explanation available): 1 patents
  • C12N13/00 (No explanation available): 1 patents
  • G01N33/4833 (No explanation available): 1 patents
• Recent patents:
  • 20250034519. HYDROGELATED CELLS (The Regents of the University of California) (20250130)

Monsanto Technology LLC

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12N15/8213 (No explanation available): 1 patents
  • C12N9/22 (No explanation available): 1 patents
  • C12N15/11 (No explanation available): 1 patents
• Recent patents:
  • 20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC) (20250130)

Northwestern University

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12Q1/02 (No explanation available): 1 patents
  • C12N1/20 (No explanation available): 1 patents
  • C12R2001/19 (No explanation available): 1 patents
• Recent patents:
  • 20250034613. ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS (Northwestern University) (20250130)

Vertex Pharmaceuticals Incorporated

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • A61K48/0058 (No explanation available): 1 patents
  • A61K38/465 (No explanation available): 1 patents
  • A61P21/00 (No explanation available): 1 patents
• Recent patents:
  • 20250064980. Materials and Methods for Treatment of Duchenne Muscular Dystrophy (Vertex Pharmaceuticals Incorporated) (20250227)

Mammoth Biosciences, Inc.

• Number of Synthetic Biology patents: 1
• Top CPC codes:
  • C12N15/52 (No explanation available): 1 patents
  • C12N9/22 (No explanation available): 1 patents
  • C12N15/11 (No explanation available): 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

New Companies in Synthetic Biology (Last Month)

800px

No new companies detected in the last month.

Emerging Technology Areas in Synthetic Biology

• G01N33/587 (No explanation available)
  • Count: 1 patents
  • Example: 20250012791. INDIUM TIN OXIDE FILM COATED UPSTANDING SILICON NANOWIRES (ITO/USNWs) AND THE USE THEREOF IN SENSITIVE NANOELECTRONIC DEVICE (NED) (National Chung Hsing University)
• C23C14/5806 (No explanation available)
  • Count: 1 patents
  • Example: 20250012791. INDIUM TIN OXIDE FILM COATED UPSTANDING SILICON NANOWIRES (ITO/USNWs) AND THE USE THEREOF IN SENSITIVE NANOELECTRONIC DEVICE (NED) (National Chung Hsing University)
• C23C14/542 (No explanation available)
  • Count: 1 patents
  • Example: 20250012791. INDIUM TIN OXIDE FILM COATED UPSTANDING SILICON NANOWIRES (ITO/USNWs) AND THE USE THEREOF IN SENSITIVE NANOELECTRONIC DEVICE (NED) (National Chung Hsing University)
• C23C14/221 (No explanation available)
  • Count: 1 patents
  • Example: 20250012791. INDIUM TIN OXIDE FILM COATED UPSTANDING SILICON NANOWIRES (ITO/USNWs) AND THE USE THEREOF IN SENSITIVE NANOELECTRONIC DEVICE (NED) (National Chung Hsing University)
• C23C14/086 (No explanation available)
  • Count: 1 patents
  • Example: 20250012791. INDIUM TIN OXIDE FILM COATED UPSTANDING SILICON NANOWIRES (ITO/USNWs) AND THE USE THEREOF IN SENSITIVE NANOELECTRONIC DEVICE (NED) (National Chung Hsing University)
• C23C14/021 (No explanation available)
  • Count: 1 patents
  • Example: 20250012791. INDIUM TIN OXIDE FILM COATED UPSTANDING SILICON NANOWIRES (ITO/USNWs) AND THE USE THEREOF IN SENSITIVE NANOELECTRONIC DEVICE (NED) (National Chung Hsing University)
• C07K16/18 (No explanation available)
  • Count: 1 patents
  • Example: 20250011781. METHODS AND COMPOSITIONS TARGETING NUCLEUS ACCUMBENS-ASSOCIATED PROTEIN-1 FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCERS (THE TEXAS A&M UNIVERSITY SYSTEM)
• A61K31/165 (No explanation available)
  • Count: 1 patents
  • Example: 20250011781. METHODS AND COMPOSITIONS TARGETING NUCLEUS ACCUMBENS-ASSOCIATED PROTEIN-1 FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCERS (THE TEXAS A&M UNIVERSITY SYSTEM)
• C12N2320/33 (No explanation available)
  • Count: 1 patents
  • Example: 20250011772. NEURODEGENERATIVE DISORDERS (Teesside University)
• C12N2310/3233 (No explanation available)
  • Count: 1 patents
  • Example: 20250011772. NEURODEGENERATIVE DISORDERS (Teesside University)

Top Companies in Emerging Synthetic Biology Technologies 2025

• National Chung Hsing University: 6 patents
• Teesside University: 2 patents
• THE TEXAS A&M UNIVERSITY SYSTEM: 2 patents

Top Inventors in Synthetic Biology

Bahram VALAMEHR of San Diego CA (US)

• Number of Synthetic Biology patents: 4
• Top companies:
  • FATE THERAPEUTICS, INC.: 3 patents
  • Fate Therapeutics, Inc.: 1 patents
• Recent patents:
  • 20250000904. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250102)
  • 20250018034. ENGINEERED EFFECTOR CELLS AND METHODS OF ENHANCING UBIQUITOUS TARGETING OF SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250116)
  • 20250009882. ENGINEERED EFFECTOR CELLS FOR TRAFFICKING OF ALLOGENEIC CELL THERAPIES IN SOLID TUMORS (Fate Therapeutics, Inc.) (20250109)

Emily CARRON of San Diego CA (US)

• Number of Synthetic Biology patents: 2
• Top companies:
  • FATE THERAPEUTICS, INC.: 2 patents
• Recent patents:
  • 20250032547. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250130)
  • 20250000904. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250102)

Eigen PERALTA of San Diego CA (US)

• Number of Synthetic Biology patents: 2
• Top companies:
  • FATE THERAPEUTICS, INC.: 2 patents
• Recent patents:
  • 20250032547. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250130)
  • 20250000904. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250102)

Hui-Yi CHU of San Diego CA (US)

• Number of Synthetic Biology patents: 2
• Top companies:
  • FATE THERAPEUTICS, INC.: 2 patents
• Recent patents:
  • 20250032547. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250130)
  • 20250000904. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250102)

Tom Tong LEE of San Diego CA (US)

• Number of Synthetic Biology patents: 2
• Top companies:
  • FATE THERAPEUTICS, INC.: 2 patents
• Recent patents:
  • 20250032547. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250130)
  • 20250000904. EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250102)

Mohammed N. ISLAM of Ann Arbor MI (US)

• Number of Synthetic Biology patents: 2
• Top companies:
  • OMNI MEDSCI, INC.: 2 patents
• Recent patents:
  • 20250017473. WEARABLE DEVICE FOR DIFFERENTIAL MEASUREMENT ON PULSE RATE AND BLOOD FLOW (OMNI MEDSCI, INC.) (20250116)
  • 20250049326. WEARABLE DEVICE FOR DIFFERENTIAL MEASUREMENT ON PULSE RATE AND BLOOD FLOW (OMNI MEDSCI, INC.) (20250213)

Martin HOSKING of San Diego CA (US)

• Number of Synthetic Biology patents: 2
• Top companies:
  • FATE THERAPEUTICS, INC.: 1 patents
  • Fate Therapeutics, Inc.: 1 patents
• Recent patents:
  • 20250018034. ENGINEERED EFFECTOR CELLS AND METHODS OF ENHANCING UBIQUITOUS TARGETING OF SOLID TUMORS (FATE THERAPEUTICS, INC.) (20250116)
  • 20250009882. ENGINEERED EFFECTOR CELLS FOR TRAFFICKING OF ALLOGENEIC CELL THERAPIES IN SOLID TUMORS (Fate Therapeutics, Inc.) (20250109)

Andrew ELLINGTON of Austin TX (US)

• Number of Synthetic Biology patents: 2
• Top companies:
  • BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM: 2 patents
• Recent patents:
  • 20250027072. METHODS AND COMPOSITIONS RELATED TO ENGINEERED CANNABINOID RECEPTORS (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM) (20250123)
  • 20250051862. METHODS AND COMPOSITIONS RELATED TO ENGINEERED BIOSENSORS (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM) (20250213)

Cheemeng TAN of Davis CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • The Regents of the University of California: 1 patents
• Recent patents:
  • 20250034519. HYDROGELATED CELLS (The Regents of the University of California) (20250130)

Luis E. CONTRERAS LLANO of Davis CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • The Regents of the University of California: 1 patents
• Recent patents:
  • 20250034519. HYDROGELATED CELLS (The Regents of the University of California) (20250130)

Che-Ming J. HU

• Number of Synthetic Biology patents: 1
• Top companies:
  • The Regents of the University of California: 1 patents
• Recent patents:
  • 20250034519. HYDROGELATED CELLS (The Regents of the University of California) (20250130)

Matthew Bauer of Manchester MO (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Monsanto Technology LLC: 1 patents
• Recent patents:
  • 20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC) (20250130)

Brent Delbert Brower-Toland of St. Louis MO (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Monsanto Technology LLC: 1 patents
• Recent patents:
  • 20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC) (20250130)

Shunhong Dai of Creve Coeur MO (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Monsanto Technology LLC: 1 patents
• Recent patents:
  • 20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC) (20250130)

Brent O'Brien of St. Charles MO (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Monsanto Technology LLC: 1 patents
• Recent patents:
  • 20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC) (20250130)

Thomas L. Slewinski of Columbia MO (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Monsanto Technology LLC: 1 patents
• Recent patents:
  • 20250034582. INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS (Monsanto Technology LLC) (20250130)

Arthur Benjamin Prindle of Evanston IL (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Northwestern University: 1 patents
• Recent patents:
  • 20250034613. ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS (Northwestern University) (20250130)

Jonathan Xia of Evanston IL (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Northwestern University: 1 patents
• Recent patents:
  • 20250034613. ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS (Northwestern University) (20250130)

Ami Meda Kabadi of Cambridge MA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Vertex Pharmaceuticals Incorporated: 1 patents
• Recent patents:
  • 20250064980. Materials and Methods for Treatment of Duchenne Muscular Dystrophy (Vertex Pharmaceuticals Incorporated) (20250227)

Chad Albert Cowan of Cambridge MA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Vertex Pharmaceuticals Incorporated: 1 patents
• Recent patents:
  • 20250064980. Materials and Methods for Treatment of Duchenne Muscular Dystrophy (Vertex Pharmaceuticals Incorporated) (20250227)

Ante Sven Lundberg of Cambridge MA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Vertex Pharmaceuticals Incorporated: 1 patents
• Recent patents:
  • 20250064980. Materials and Methods for Treatment of Duchenne Muscular Dystrophy (Vertex Pharmaceuticals Incorporated) (20250227)

Lucas Benjamin HARRINGTON of San Francisco CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

William Douglass WRIGHT of Fairfield CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

Pei-Qi LIU of Oakland CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

Benjamin Julius RAUCH of San Francisco CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

Wiputra Jaya HARTONO of San Francisco CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

Bridget Ann Paine MCKAY of Portola Valley CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

Danuta Sastre PHIPPS of San Mateo CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

Yuxuan ZHENG of San Jose CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

Nerea SANVISENS of San Francisco CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

Sean CHEN of Brisbane CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

David PAEZ-ESPINO of Concord CA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Mammoth Biosciences, Inc.: 1 patents
• Recent patents:
  • 20250066797. PROGRAMMABLE NUCLEASES AND METHODS OF USE (Mammoth Biosciences, Inc.) (20250227)

Jin-Soo Kim

• Number of Synthetic Biology patents: 1
• Top companies:
  • ToolGen Incorporated: 1 patents
• Recent patents:
  • 20250066798. COMPOSITIONS FOR INDUCING MODIFICATIONS OF TARGET ENDOGENOUS NUCLEIC ACID SEQUENCES IN NUCLEUSES OF EUKARYOTIC CELLS (ToolGen Incorporated) (20250227)

Seung Woo Cho

• Number of Synthetic Biology patents: 1
• Top companies:
  • ToolGen Incorporated: 1 patents
• Recent patents:
  • 20250066798. COMPOSITIONS FOR INDUCING MODIFICATIONS OF TARGET ENDOGENOUS NUCLEIC ACID SEQUENCES IN NUCLEUSES OF EUKARYOTIC CELLS (ToolGen Incorporated) (20250227)

Sojung Kim

• Number of Synthetic Biology patents: 1
• Top companies:
  • ToolGen Incorporated: 1 patents
• Recent patents:
  • 20250066798. COMPOSITIONS FOR INDUCING MODIFICATIONS OF TARGET ENDOGENOUS NUCLEIC ACID SEQUENCES IN NUCLEUSES OF EUKARYOTIC CELLS (ToolGen Incorporated) (20250227)

Rebecca Ann WILKES of Lakewood CO (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Alliance for Sustainable Energy, LLC: 1 patents
• Recent patents:
  • 20250066823. METHODS FOR ENGINEERING OUTER MEMBRANE VESICLE PRODUCTION AND CARGO PACKAGING IN PSEUDOMONAS PUTIDA (Alliance for Sustainable Energy, LLC) (20250227)

Allison Jean ZIMONT WERNER of Denver CO (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Alliance for Sustainable Energy, LLC: 1 patents
• Recent patents:
  • 20250066823. METHODS FOR ENGINEERING OUTER MEMBRANE VESICLE PRODUCTION AND CARGO PACKAGING IN PSEUDOMONAS PUTIDA (Alliance for Sustainable Energy, LLC) (20250227)

Tarryn E. MILLER of Wheat Ridge CO (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Alliance for Sustainable Energy, LLC: 1 patents
• Recent patents:
  • 20250066823. METHODS FOR ENGINEERING OUTER MEMBRANE VESICLE PRODUCTION AND CARGO PACKAGING IN PSEUDOMONAS PUTIDA (Alliance for Sustainable Energy, LLC) (20250227)

Gregg Tyler BECKHAM of Golden CO (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • Alliance for Sustainable Energy, LLC: 1 patents
• Recent patents:
  • 20250066823. METHODS FOR ENGINEERING OUTER MEMBRANE VESICLE PRODUCTION AND CARGO PACKAGING IN PSEUDOMONAS PUTIDA (Alliance for Sustainable Energy, LLC) (20250227)

Bruno BOTTA

• Number of Synthetic Biology patents: 1
• Top companies:
  • BIOSENSING S.R.L.: 1 patents
• Recent patents:
  • 20250067701. ELECTROCHEMICAL TYPE BIOSENSORS COMPRISING RESORCARENES (BIOSENSING S.R.L.) (20250227)

Francesca GHIRGA

• Number of Synthetic Biology patents: 1
• Top companies:
  • BIOSENSING S.R.L.: 1 patents
• Recent patents:
  • 20250067701. ELECTROCHEMICAL TYPE BIOSENSORS COMPRISING RESORCARENES (BIOSENSING S.R.L.) (20250227)

Deborah QUAGLIO

• Number of Synthetic Biology patents: 1
• Top companies:
  • BIOSENSING S.R.L.: 1 patents
• Recent patents:
  • 20250067701. ELECTROCHEMICAL TYPE BIOSENSORS COMPRISING RESORCARENES (BIOSENSING S.R.L.) (20250227)

Andrea CALCATERRA

• Number of Synthetic Biology patents: 1
• Top companies:
  • BIOSENSING S.R.L.: 1 patents
• Recent patents:
  • 20250067701. ELECTROCHEMICAL TYPE BIOSENSORS COMPRISING RESORCARENES (BIOSENSING S.R.L.) (20250227)

Cristina DEL PLATO

• Number of Synthetic Biology patents: 1
• Top companies:
  • BIOSENSING S.R.L.: 1 patents
• Recent patents:
  • 20250067701. ELECTROCHEMICAL TYPE BIOSENSORS COMPRISING RESORCARENES (BIOSENSING S.R.L.) (20250227)

Franco MAZZEI

• Number of Synthetic Biology patents: 1
• Top companies:
  • BIOSENSING S.R.L.: 1 patents
• Recent patents:
  • 20250067701. ELECTROCHEMICAL TYPE BIOSENSORS COMPRISING RESORCARENES (BIOSENSING S.R.L.) (20250227)

Francesca POLLI

• Number of Synthetic Biology patents: 1
• Top companies:
  • BIOSENSING S.R.L.: 1 patents
• Recent patents:
  • 20250067701. ELECTROCHEMICAL TYPE BIOSENSORS COMPRISING RESORCARENES (BIOSENSING S.R.L.) (20250227)

Siu Lun WONG

• Number of Synthetic Biology patents: 1
• Top companies:
  • The University of Hong Kong: 1 patents
• Recent patents:
  • 20250069690. MACHINE LEARNING-BASED SYSTEM USING LOW-N LEARNING TO ACCURATELY IDENTIFY VARIANTS FOR ENGINEER GENOME EDITING PROTEINS (The University of Hong Kong) (20250227)

Hoi Yee CHU

• Number of Synthetic Biology patents: 1
• Top companies:
  • The University of Hong Kong: 1 patents
• Recent patents:
  • 20250069690. MACHINE LEARNING-BASED SYSTEM USING LOW-N LEARNING TO ACCURATELY IDENTIFY VARIANTS FOR ENGINEER GENOME EDITING PROTEINS (The University of Hong Kong) (20250227)

ALYSSA MARIE DELEON of DES MOINES IA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • PIONEER HI-BRED INTERNATIONAL, INC.: 1 patents
• Recent patents:
  • 20250000042. COMPOSITIONS AND METHODS FOR GRAY LEAF SPOT RESISTANCE (PIONEER HI-BRED INTERNATIONAL, INC.) (20250102)

SABRINA HUMBERT of JOHNSTON IA (US)

• Number of Synthetic Biology patents: 1
• Top companies:
  • PIONEER HI-BRED INTERNATIONAL, INC.: 1 patents
• Recent patents:
  • 20250000042. COMPOSITIONS AND METHODS FOR GRAY LEAF SPOT RESISTANCE (PIONEER HI-BRED INTERNATIONAL, INC.) (20250102)

Top Collaborations in Synthetic Biology

Top US States for Synthetic Biology Inventors

Top Cities for Synthetic Biology Inventors

• San Diego: 21 inventors
• San Francisco: 8 inventors
• Austin: 8 inventors
• Rome: 7 inventors
• Cambridge: 6 inventors
• Johnston: 5 inventors
• San Jose: 4 inventors
• Zhengzhou: 4 inventors
• Baltimore: 4 inventors
• Frankfurt am Main: 4 inventors
• Wuhan, Hubei: 4 inventors
• Egham: 4 inventors
• Taichung City: 4 inventors
• St. Louis: 3 inventors
• Brisbane: 3 inventors
• Seoul: 3 inventors
• Zwijnaarde: 3 inventors
• Houston: 3 inventors
• Cairo: 3 inventors
• New Cairo: 3 inventors